USPTO serial 79010986
EZ-ANTOX
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEVERLY, JOSETTE MICHELLE
- Law office
- TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EZ-ANTOX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Annemette Ellermann
ANNEMETTE ELLERMANN HOJBRO PLADS 10JOHAN SCHLUTER LAW FIRMCOPENHAGEN K DK, 1200DENMARKGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for the treatment of cardiovascular diseases, artheroschlerosis, capillary fragility, cancer, inflammatory diseases and conditions, Attention Deficiency Hyperactivity Disorder; psoreasis, protein kinase inhibit effect, chronic venous insufficiency, erectile dysfunction, collagen stablization, diabtic retinopathy, edema, occular stress, pancreatitis, premenstrual syndrome; preparations for medical use for the treatment of cardiovascular diseases, artheroschlerosis, capillary fragility, cancer, inflammatory diseases and conditions, Attention Deficiency Hyperactivity Disorder; psoreasis, protein kinase inhibit effect, chronic venous insufficiency, erectile dysfunction, collagen stablization, diabtic retinopathy, edema, occular stress, pancreatitis, premenstrual syndrome; food for babies; biopathic products, namely, non-medicated preparations for the treatment of cardiovascular diseases, artheroschlerosis, capillary fragility, cancer, inflammatory diseases and conditions, Attention Deficiency Hyperactivity Disorder; psoreasis, protein kinase inhibit effect, chronic venous insufficiency, erectile dysfunction, collagen stablization, diabtic retinopathy, edema, occular stress, pancreatitis, premenstrual syndrome; pharmaceutical preparations for skin care and sun protection, medical and therapeutic bath preparations, medicated confectionery, preparations for hair growth for medical purposes, herb preparations for medical use, enzyme preparations for medical use, preparations for treatment of burns; preparations to promote digestion for pharmaceutical purposes | ACTIVE | — |
| 029 | Non-medical preparations for human use consisting of processed extracts of and active parts from fruit, vegetables and plants, sea plants, marine animals as well as fish and shellfish for cardiovascular diseases, artheroschlerosis, capillary fragility, cancer, inflammatory diseases and conditions, Attention Deficiency Hyperactivity Disorder; psoreasis, protein kinase inhibit effect, chronic venous insufficiency, erectile dysfunction, collagen stablization, diabtic retinopathy, edema, occular stress, pancreatitis, premenstrual syndrome | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 18, 2006 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 16, 2006 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 16, 2006 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 30, 2006 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2006 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 2, 2006 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 2, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 30, 2006 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2006 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 26, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 4, 2005 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 18, 2005 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 16, 2005 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 15, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 17, 2005 | NWAP | NEW APPLICATION ENTERED | — |
| Jun 16, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |